R&G PharmaStudies Co., Ltd.

SZSE:301333 Stock Report

Market Cap: CN¥3.7b

R&G PharmaStudies Dividend

Dividend criteria checks 2/6

R&G PharmaStudies is a dividend paying company with a current yield of 0.52% that is well covered by earnings.

Key information

0.5%

Dividend yield

12%

Payout ratio

Industry average yield1.7%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.200
Earnings per shareCN¥1.41
Dividend yield forecast0.6%

Recent dividend updates

R&G PharmaStudies' (SZSE:301333) Dividend Will Be Reduced To CN¥0.20

Jul 01
R&G PharmaStudies' (SZSE:301333) Dividend Will Be Reduced To CN¥0.20

Recent updates

R&G PharmaStudies' (SZSE:301333) Dividend Will Be Reduced To CN¥0.20

Jul 01
R&G PharmaStudies' (SZSE:301333) Dividend Will Be Reduced To CN¥0.20

Is There An Opportunity With R&G PharmaStudies Co., Ltd.'s (SZSE:301333) 27% Undervaluation?

Jun 06
Is There An Opportunity With R&G PharmaStudies Co., Ltd.'s (SZSE:301333) 27% Undervaluation?

Shareholders Will Be Pleased With The Quality of R&G PharmaStudies' (SZSE:301333) Earnings

Apr 29
Shareholders Will Be Pleased With The Quality of R&G PharmaStudies' (SZSE:301333) Earnings

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Too early to tell whether 301333's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if 301333's dividend payments are increasing as they only just started paying a dividend.


Dividend Yield vs Market

R&G PharmaStudies Dividend Yield vs Market
How does 301333 dividend yield compare to the market?
SegmentDividend Yield
Company (301333)0.5%
Market Bottom 25% (CN)0.8%
Market Top 25% (CN)2.8%
Industry Average (Life Sciences)1.7%
Analyst forecast (301333) (up to 3 years)0.6%

Notable Dividend: 301333's dividend (0.52%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.75%).

High Dividend: 301333's dividend (0.52%) is low compared to the top 25% of dividend payers in the CN market (2.75%).


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (11.6%), 301333's dividend payments are thoroughly covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (9.9%), 301333's dividend payments are thoroughly covered by cash flows.


Discover strong dividend paying companies